Skip to content
Medical Health Aged Care, National News Current Affairs

Breast Cancer Network Australia (BCNA) alarmed about delays in diagnosis and access to treatment for breast cancer in Queensland

Breast Cancer Network Australia < 1 mins read

5 August 2023 

 

Breast Cancer Network Australia (BCNA) is alarmed people in Queensland are waiting months for test results to confirm breast cancer and then delays for treatment after a diagnosis. 

BCNA Director Policy, Advocacy and Support Services Vicki Durston said reports of these delays are deeply concerning. 

BCNA is calling for transparency to know the extent of the problem, how many are affected and what the Queensland Government is doing to address the immediate situation. 

‘We have been hearing from BCNA members about unacceptable waiting times to diagnose and treat breast cancer,’ Ms Durston said. 

'This is critical and unacceptable – because cancer does not wait.’ 

‘It’s unbelievable that after 25 years of BCNA advocating for better access to care, treatment and support, we are in a situation where it is now being reported that people in Queensland are waiting months to get diagnosed and access to life saving treatment,’ Ms Durston. 

'Without timely diagnosis and access to immediate treatment breast cancer may progress and people with early-stage disease may face a reduced option for cure.’ 

 

 

 

For media enquiries contact: 

Anna Malbon 

Media and Communications 

0498 999 477 


About us:

Breast Cancer Network Australia (BCNA) is Australia’s leading breast cancer consumer organisation. BCNA provides information and support to those diagnosed and their supporters, opportunities to connect with others going through a similar situation and work to influence a stronger healthcare system to ensure all Australians affected by breast cancer receive the very best care, treatment and support.


Contact details:

 

 

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 18/12/2025
  • 06:00
Leukaemia Foundation

Leading Haematologist Professor John Seymour AM joins Leukaemia Foundation Board

The Leukaemia Foundation is delighted to announce the appointment of Professor John Seymour to its Board, effective immediately. With more than three decades of world-class leadership in haematology, research and patient care, Professor Seymour brings exceptional clinical and translational expertise to the Leukaemia Foundation Board – a major asset as we work to accelerate progress in blood cancer treatment, care and outcomes. Professor Seymour is an internationally recognised haematologist who until recently led the Haematology Department at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital. Holding MBBS, FRACP, PhD and fellowship of the Australian Academy of Health and Medical…

  • Medical Health Aged Care
  • 18/12/2025
  • 04:56
TruMerit

TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / December 17, 2025 / TruMerit, a worldwide leader in international credentials evaluation to support health worker careers, and…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 02:00
Alcoholics Anonymous

ALCOHOLICS ANONYMOUS’ 2025 SURVEY MEMBERS AND THEIR RECOVERY JOURNEYS

ALCOHOLICS ANONYMOUS’ 2025 MEMBER SURVEY ALCOHOLICS ANONYMOUS MEMBERS AND THEIR RECOVERY JOURNEYS Sydney. A recent survey of over 1,000 current AA participants across Australia has explored in detail how AA supports its members in their recovery from addiction. The results also emphasise the “ordinary” nature of AA membership, being broadly consistent with the general Australian demography. 8 Key Details. Membership was almost equally divided between men and women, with 3% of members identifying as First Nations. 46% reported as holding a University Bachelor’s degree or above. Only 3.9% of respondents reported as being unemployed, with almost 60% employed and 34%…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.